Recombinant B7-H3 (Enoblituzumab Biosimilar) anticorps

N° du produit ABIN6964423

Cet anticorps anti-B7-H3 (Enoblituzumab Biosimilar) est un anticorps Humanized Monoclonal détectant B7-H3 (Enoblituzumab Biosimilar) dans ELISA et FACS. Adapté pour Humain.

Aperçu rapide pour Recombinant B7-H3 (Enoblituzumab Biosimilar) anticorps (ABIN6964423)

Antigène: B7-H3 (Enoblituzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp B7-H3 (Enoblituzumab Biosimilar) est non-conjugé

Application: ELISA, Flow Cytometry (FACS)

Classe de qualité: Research Grade

Détail du produit anti-B7-H3 (Enoblituzumab Biosimilar) anticorps

Fonction: Anti-B7-H3 (enoblituzumab biosimilar) mAb

Attributs du produit: MG-A271, MGA271

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Information d'application

Indications d'application: Flow Cyt 1/100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur B7-H3 (Enoblituzumab Biosimilar)

Antigène: B7-H3 (Enoblituzumab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: B7-H3, CD276, B7 homolog 3

UniProt: Q5ZPR3